PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX??? for the Prevention of Abdominal Colorectal Surgical Site Infections

Stock Information for PolyPid Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PolyPid Ltd.

PolyPid to Participate in Three Upcoming Fall Investor Conferences
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX??? Phase 3 Trial
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
PolyPid to Participate in Citizens JMP Life Sciences Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.